A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TN / tenascin

[Related PubMed/MEDLINE]
Total Number of Papers: 180
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TN  (>> Co-occurring Abbreviation)
Long Form:   tenascin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats. ECM, MCT, OPN, RV, TSP
2015 Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis. CIs, ECM, ORs, SMDs
2015 Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit. ECM
2015 Immunohistochemical Evaluation of Fibronectin and Tenascin Following Direct Pulp Capping with Mineral Trioxide Aggregate, Platelet-Rich Plasma and Propolis in Dogs' Teeth. DPC, FN, MTA, PRP
2015 Tenascin-X: beyond the architectural function. TGF
2014 Targeting the extracellular matrix: matricellular proteins regulate cell-extracellular matrix communication within distinct niches of the intervertebral disc. ECM, POSTN, TSP
2014 The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature. BSP, FN, MSCs, OPN
2013 Tenascin and fibronectin expression after pulp capping with different hemostatic agents: a preliminary study. CH, FN
2012 Promoting effects of carminic acid-enriched cochineal extracts on capsular invasive thyroid carcinomas through targeting activation of angiogenesis in rats. CA, CA, CA, CE, CICs, PHBP, PTEN
10  2012 [Expression of some biomarkers in primary colon adenocarcinomas and their lymph node metastases]. CAC, EGFR, TS, VEGF
11  2011 Histologic response and tenascin and fibronectin expression after pulp capping in pig primary teeth with mineral trioxide aggregate or calcium hydroxide. CH, FN, MTA
12  2011 Immunohistochemical expression of fibronectin and tenascin in human tooth pulp capped with mineral trioxide aggregate and a novel endodontic cement. FN, MTA, NEC
13  2010 Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix. MMP, PKC
14  2009 Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. DC, MMP-9, NDC
15  2008 Alteration of inflammatory cytokine production in the injured central nervous system of tenascin-deficient mice. CNS, IL, WT
16  2008 Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT1 receptor. CysLTs, LN, LTD4
17  2007 Central giant cell granuloma of the jaws and giant cell tumor of long bones: an immunohistochemical comparative study. CGCG, FN, GCT
18  2007 Immunohistochemical expression of tenascin in melanocytic tumours of dogs. vWF
19  2007 Tenascin-C is required for proliferation of astrocytes in primary culture. ---
20  2006 Effect of GaAIAs laser on reactional dentinogenesis induction in human teeth. Col III, FN, GaAlAs, SABC
21  2006 Histological changes in the liver of fetuses of alcohol-treated pregnant rats. PAP
22  2006 Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. FN, IF
23  2006 Tenascin and fibronectin in pleomorphic adenoma of the salivary gland. FN
24  2005 Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. DC, MC
25  2005 Cellular and molecular tunnels surrounding the forebrain commissures of human fetuses. CS, ECM, FN, GFAP, MAP-2, NeuN, NF, VN, wpo
26  2005 Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. CEA, HUVEC, MVD, NSCLC, OPN, SLX, VEGF
27  2005 The effects of alcohol on rat placenta. ---
28  2004 Different titanium surfaces modulate the bone phenotype of SaOS-2 osteoblast-like cells. CoI, FN, SB, TPS, VN
29  2004 Glomerular capillary tenascin staining in renal allografts and its correlation with capillary loop 'double contours', proteinuria and graft outcome. CAN, GC-TN
30  2004 In vitro immunoexpression of extracellular matrix proteins in dental pulpal and gingival human fibroblasts. ECM, FN, LM, ONEC
31  2004 Regulation of tenascin expression in cultured rat dental pulp cells. bFGF, EGF, FN, HGF, RA, RT-PCR, TGF-beta1
32  2003 A study of the extracellular matrix in salivary gland tumors. ACC, BCA, BM, ECM, FN, LN, PA, PLGA
33  2003 Expression of fibronectin and tenascin as a demonstration of vital reaction in rat skin and muscle. FN
34  2003 Matricellular proteins as modulators of wound healing and the foreign body response. ECM, OPN, TSP
35  2003 Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. OA
36  2002 Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. DCIS, TN16
37  2002 Expression of tenascin and fibronectin in nasal polyps. EOS, FN, NP
38  2002 Immunohistochemical detection of fibronectin and tenascin in incised human skin injuries. FN
39  2002 Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. CD, CD44s, Coll, ECM, FN, LN
40  2002 Tenascin expression in normal, hyperplastic, and neoplastic endometrium. ECM
41  2002 The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. SPARC, TSP-1
42  2002 [Expression of extracellular matrix glycoprotein tenascin in the laryngeal cancer]. ---
43  2002 [Expression of tenascin and fibronectin in nasal polyps]. EOS, FN
44  2001 The disintegrin kistrin inhibits neurite extension from spiral ganglion explants cultured on laminin. LN, SG
45  2000 Alterations in extracellular matrix components in transplant glomerulopathy. ECM, FN
46  2000 Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neurites. CS, FN, GAGs, HS, LN
47  2000 Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. MMPs, OPN, SMCs
48  2000 Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices. CD, PCNA
49  2000 Immunohistochemical localization of tenascin, fibronectin, and type III collagen in human dental pulp. FN
50  2000 Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. CIN
51  2000 Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas. ECM
52  2000 Tenascin patterns of expression in duct carcinoma in situ of the breast. DCIS
53  2000 The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. AA, FN, GB, LN
54  2000 The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. ECM
55  2000 [Expression of glial, neurospecific, and extracellular antigens during retinal regeneration in adult newts]. GFAP
56  1999 Corneal wound healing in tenascin knockout mouse. FN, KO
57  1999 Enhanced tenascin expression correlates with inflammation in primary sclerosing cholangitis. alpha-SMA, ECM, PSC
58  1999 Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. SCC
59  1999 Extracellular matrix and development of lamination in the dorsal lateral geniculate nucleus in the tree shrew (Tupaia belangeri). PNA, VIM
60  1999 Mechanical loading regulates tenascin-C expression in the osteotendinous junction. OTJ
61  1999 Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. MMPs, PA, SMCs
62  1999 Regular albuterol or nedocromil sodium--effects on airway subepithelial tenascin in asthma. FEV1
63  1999 Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. BSA, FSH, hCG, IGF, TGF
64  1999 Tenascin is expressed in the mesenchyme of the embryonic lung and down-regulated by dexamethasone in early organogenesis. ---
65  1999 Tenascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis. ---
66  1999 TGF-beta2, tenascin, and integrin beta1 expression in superior limbic keratoconjunctivitis. SLK, TGF
67  1999 The expression of transforming growth factor beta (TGF-beta) in the synovial membrane of human temporomandibular joint with internal derangement: a comparison with tenascin expression. TGF-beta, TMJ
68  1998 Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization. ECM, FN, LN, MES
69  1998 Corneal wound healing after laser in situ keratomileusis in rabbits. EDA-cFn, LASIK
70  1998 Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. CS, ECM, FN, pw
71  1998 Domains of tenascin involved in glioma migration. FNIII
72  1998 Extracellular matrix in renal cell carcinomas. BM, ECM, EDA-Fn, Int, LN, RCCs
73  1998 Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin. cFN, ECM, mAb, PLA
74  1998 Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Col III
75  1998 Molecular tunnels and boundaries for growing axons in the anterior commissure of hamster embryos. AC, CSPG, FN, GFAP, LN
76  1998 Reduced mRNA expression of neuropeptide Y in the limbic system of tenascin gene disrupted mouse brain. NPY
77  1998 Surface topography and serum concentration affect the appearance of tenascin in human gingival fibroblasts in vitro. HGF
78  1998 Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. cDNA, ECM, FN, TGF-beta, TNF-alpha
79  1998 Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma. IDCC
80  1998 Tenascin suppresses CD3-mediated T cell activation. FN, LFA-1, VLA
81  1998 The effects of central administration of neuropeptide Y on behavior of tenascin-gene knockout mice. NPY
82  1997 Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. ECM, FN
83  1997 Effect of snuff and smoking on tenascin expression in oral mucosa. ---
84  1997 Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice. CCK, DA, TH
85  1997 Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. HSPGs, LTB4
86  1997 Expression of tenascin in mesangial injury in experimental glomerulonephritis. MPGN
87  1997 Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer. ---
88  1997 Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. ---
89  1997 Neuronal differentiation in SH-SY5Y human neuroblastoma cells induces synthesis and secretion of tenascin and upregulation of alpha(v) integrin receptors. EDA-Fn, Int, RA, TPA
90  1997 Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells. DMTU, MCT, PAECs
91  1997 Preprotachykinin A and cholecystokinin mRNAs in tenascin-gene knockout mouse brain. CCK, PPT
92  1997 Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis. ---
93  1997 Tenascin-C expression in ultrastructurally defined angiogenic and vasculogenic lesions. PI
94  1997 Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. EGF, FN, PCNA
95  1997 The change in tenascin expression in mouse uterus during early pregnancy. ---
96  1997 The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. EDA-Fn, EDB-Fn, FN, mAbs, onc-Fn
97  1997 The specific expression of tenascin in the synovial membrane of the temporomandibular joint with internal derangement: an immunohistochemical study. TMJ
98  1997 Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint. Report of a case. SC, TGF, TMJ
99  1997 Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse. TH
100  1996 Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. DA